Nat Clin Pract Rheumatol. 2007 Aug;3(8):422-3. Epub 2007 Jun 12.

Biologic agents and liver toxicity: an added concern or therapeutic opportunity?

Source

Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44118, USA. calabri@ccf.org

PMID:: 17563777; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Save items

Related citations in PubMed

Monitoring biological therapies in psoriatic arthritis. [J Rheumatol Suppl. 2009]
Monitoring biological therapies in psoriatic arthritis.
Spadaro A, Scrivo R, Spinelli FR, Valesini G. J Rheumatol Suppl. 2009 Aug; 83:69-70.
Review [Therapeutic update in gastroenterology]. [Rev Med Liege. 2007]
Review [Therapeutic update in gastroenterology].
Belaiche J, Delwaide J, Polus M, Louis E. Rev Med Liege. 2007 May-Jun; 62(5-6):303-9.
Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients. [Clin Rheumatol. 2009]
Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients.
Li S, Kaur PP, Chan V, Berney S. Clin Rheumatol. 2009 Jul; 28(7):787-91. Epub 2009 Mar 17.
Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C. [Am J Gastroenterol. 2008]
Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA, Liaskos C, Rigopoulou EI, Togousidis E, Makaritsis K, Germenis A, Dalekos GN. Am J Gastroenterol. 2008 Mar; 103(3):605-14. Epub 2008 Jan 8.
Review Treatment strategies for a patient with rheumatoid arthritis and hepatitis C. [Expert Opin Pharmacother. 2009]
Review Treatment strategies for a patient with rheumatoid arthritis and hepatitis C.
Giannitti C, Bellisai F, Ferri C, Galeazzi M. Expert Opin Pharmacother. 2009 Mar; 10(4):579-87.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Biologic agents and liver toxicity: an added concern or therapeutic opportunity?
Biologic agents and liver toxicity: an added concern or therapeutic opportunity?
Nat Clin Pract Rheumatol. 2007 Aug ;3(8):422-3. Epub 2007 Jun 12 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Biologic agents and liver toxicity: an added concern or therapeutic opportunity?

Source

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information